The legacy of Viagra offers a complex case study for investors eyeing pharma. While initial sales were astounding, current patent lapse and the emergence of cheaper versions have severely influenced profitability. https://tessnwil395403.theideasblog.com/41498107/the-blue-pill-and-pharma-a-precarious-bet